DUBLIN--(BUSINESS WIRE)--The "Microbubbles/Ultrasound Contrast Agents Market - Global Opportunity Analysis and Industry Forecast (2018-2024)" report has been added to ResearchAndMarkets.com's offering.
Global Microbubbles/Ultrasound Contrast Agents Market is expected to reach USD 1,584.5 million by 2024, at a CAGR of 25.2% during the forecast period of 2018 to 2024.
Succeeding an extensive secondary and primary research on microbubbles/ultrasound contrast agents and in-depth analysis of the market scenario, the report carries out an impact analysis of the key industry drivers, restraints, opportunities, and trends in the market dynamics segment.
Advancement in ultrasound technologies, benefits over alternative technologies, favorable reimbursement policies for contrast enhanced procedures in the U.S., increase in demand for diagnostics & image guided procedures, and growing aging population and subsequent rise in the prevalence of chronic diseases are majorly driving the microbubbles/ultrasound contrast agents market. However, factors such as complexity involved in conducting contrast enhanced ultrasound (CEUS) procedures retard the growth of this market.
The report also includes the competitive landscape based on extensive assessment of the key strategic developments adopted by leading market participants in the industry over the past 4 years (2014-2017).
The key players in the global microbubbles/ultrasound contrast agents market are Lantheus Holdings, Inc., Bracco, GE Healthcare, Daiichi Sankyo Company, Limited, and nanoPET Pharma GmbH.
Scope of the report
Market by Therapeutic Area:
- Cardiovascular diseases
- Renal and associated diseases
Market by Application:
- Molecular imaging
- Gene therapy
- Drug delivery
- Stem cells delivery
Key Topics Covered:
2. Research Methodology
3. Executive Summary
4. Market Insights
5. Microbubbles/Ultrasound Contrast Agents Market, by Therapeutic Area
6. Microbubbles/Ultrasound Contrast Agents Market, by Application
7. Microbubbles/Ultrasound Contrast Agents Market, by Geography
8. Competitive Landscape
9. Company Profiles
- Lantheus Holdings Inc.
- GE Healthcare
- Daiichi Sankyo Company Limited
- NanoPET Pharma GmbH
For more information about this report visit https://www.researchandmarkets.com/research/24jxn6/1_58_billion?w=4